Risk alert: FDA relabels intragastric balloon systems due to possible related deaths

June 4, 2018 Wayne Wenske

In collaboration with manufacturers Apollo Endosurgery and ReShape LifeSciences, the FDA has approved new labeling for the Orbera and ReShape balloon systems to include more information about possible deaths associated with the use of these devices.

Both of these systems consist of liquid-filled balloons used as weight loss devices to treat obesity.

The FDA is recommending that health care providers:

instruct patients regarding symptoms of potentially life-threatening complications such as balloon deflation, gastrointestinal obstruction, ulceration, and gastric and esophageal perforation; and
monitor patients closely during treatment with these systems for potential complications, including acute pancreatitis and spontaneous hyperinflation.

Health care professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. Instructions are found on the FDA website.

About the Author

Wayne Wenske is Senior Marketing Coordinator at Texas Medical Liability Trust. He can be reached at wayne-wenske@tmlt.org.
More Content by Wayne Wenske

Suicide awareness and prevention

Recent events and reports offer a reminder that effective suicide prevention resources are available to the...

Risk alert: Birth control pills recalled

Allergan recalls sample packs of Taytulla birth control pills

Risk alert: FDA relabels intragastric balloon systems due to possible related deaths

About the Author

Previous Article

Next Article

Risk alert: FDA relabels intragastric balloon systems due to possible related deaths

About the Author

Previous Article

Next Article

Most Recent Articles

A compilation of medical malpractice claim data from January 1, 2006 to December 31, 2015, submitted by member companies of the Medical Professional Liability Association (MPL Association).

Texas physicians will be required to use a new system to submit death certificates beginning January 1, 2019.

Texas physicians will be required to use new schedule II prescription forms beginning June 1, 2019.

The TMDP has revised the lists of medical and surgical procedures that require the disclosure of specific risks and informed consent.

It is imperative to have a system in place that allows the release of complete, legible, and organized records from your medical office.

During the current "boil water advisory," Austin residents are encouraged to boil water before drinking or cooking. Daily routines, such as hand washing and bathing, require a little planning.

The TMLT Scholarship was established to recognize Texas medical students who are interested in finding creative and effective ways to enhance patient safety.

Anthem will pay $16 million after cyber attacks exposed the ePHI of 79 million people

TMLT policyholders will receive a 10 percent dividend when they renew their policies in 2019.

Millennials are now the largest segment of our population, and they bring a different set of expectations and needs to health care than previous generations.

According to the FBI, human trafficking is the third-largest criminal activity in the world. (1) A form of human slavery, human trafficking is an estimated $32 billion a year industry.

Texas Governor issues proclamation marking the 15th anniversary of Texas medical liability reforms

Improper disposal of electronic devices and media puts the information stored on those devices at risk for a breach. And when devices contain protected health information (PHI), it puts your patient’s

The story of TMLT

MD Anderson Cancer Center was recently fined for HIPAA violations. Let's go behind the headlines and take a look at the case.

Recent events and reports offer a reminder that effective suicide prevention resources are available to the public and to health care providers for sharing with their patients.

Allergan recalls sample packs of Taytulla birth control pills

For this year’s spring CME seminars, attorney Brett B. Rowe presented “How to Fight the Opioid Epidemic” in Austin and Houston. Here’s a brief recap with five risk management takeaways for physicians.

The financial impact of a data breach can be much greater than expected.

Criminals posing as U.S. Drug Enforcement Administration (DEA) agents are phoning physicians and requesting payment for false fines.